MIT researchers have developed a robotic capsule that tunnels through mucus in the GI tract to deliver large oral protein-based drugs like insulin.
Scientists at MIT have demonstrated that a novel robotic capsule could potentially replace conventional biologic injection methods by tunnelling through the intestinal mucus barrier to deliver insulin.
The research, published in the journal Science Robotics described how the new drug delivery system can transport large protein and small-molecule drugs, like vancomycin, an antibiotic peptide.
Traditionally, delivering protein drugs orally has been challenging. The mucosal lining of the small intestine prevents large molecules passing into cells. The acidic nature of the digestive tract also presents a barrier by breaking down drugs before they can be absorbed.
To solve this problem, the team at MIT developed a multivitamin-sized capsule that tunnels through mucus.
The RoboCap capsule carries its drug payload in a small reservoir at one end and carries the tunnelling features in its main body and surface. The capsule is coated with gelatine that can be tuned to dissolve at a specific pH.
Once dissolved, the change in pH triggers a motor to start spinning inside the capsule. This motion helps the capsule to tunnel into the mucus and displace it. The capsule is also coated with small studs that brush mucus away. The spinning action helps to erode the compartment that carries the drug, so the drug can be gradually released into the digestive tract.
Continue reading… “Robotic capsule could replace injected biologics”
